These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 33163486)
1. Senescence and the Aging Immune System as Major Drivers of Chronic Kidney Disease. Schroth J; Thiemermann C; Henson SM Front Cell Dev Biol; 2020; 8():564461. PubMed ID: 33163486 [TBL] [Abstract][Full Text] [Related]
2. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases. Lagoumtzi SM; Chondrogianni N Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756 [TBL] [Abstract][Full Text] [Related]
3. Ageing, cellular senescence and chronic kidney disease: experimental evidence. Tan H; Xu J; Liu Y Curr Opin Nephrol Hypertens; 2022 May; 31(3):235-243. PubMed ID: 35142744 [TBL] [Abstract][Full Text] [Related]
4. Macrophage-derived exosomes promote telomere fragility and senescence in tubular epithelial cells by delivering miR-155. Yin Q; Tang TT; Lu XY; Ni WJ; Yin D; Zhang YL; Jiang W; Zhang Y; Li ZL; Wen Y; Gan WH; Zhang AQ; Lv LL; Wang B; Liu BC Cell Commun Signal; 2024 Jul; 22(1):357. PubMed ID: 38987851 [TBL] [Abstract][Full Text] [Related]
5. Targeting Premature Renal Aging: from Molecular Mechanisms of Cellular Senescence to Senolytic Trials. Franzin R; Stasi A; Ranieri E; Netti GS; Cantaluppi V; Gesualdo L; Stallone G; Castellano G Front Pharmacol; 2021; 12():630419. PubMed ID: 33995028 [TBL] [Abstract][Full Text] [Related]
6. Senolytic therapy ameliorates renal fibrosis postacute kidney injury by alleviating renal senescence. Li C; Shen Y; Huang L; Liu C; Wang J FASEB J; 2021 Jan; 35(1):e21229. PubMed ID: 33368613 [TBL] [Abstract][Full Text] [Related]
7. Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies. Xu J; Zhou L; Liu Y Front Pharmacol; 2020; 11():601325. PubMed ID: 33362554 [TBL] [Abstract][Full Text] [Related]
8. Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools. Knoppert SN; Valentijn FA; Nguyen TQ; Goldschmeding R; Falke LL Front Pharmacol; 2019; 10():770. PubMed ID: 31354486 [TBL] [Abstract][Full Text] [Related]
15. Implication of cellular senescence in the progression of chronic kidney disease and the treatment potencies. Wang Y; Wang Y; Yang M; Ma X Biomed Pharmacother; 2021 Mar; 135():111191. PubMed ID: 33418306 [TBL] [Abstract][Full Text] [Related]
16. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies. Khalil R; Diab-Assaf M; Lemaitre JM Cells; 2023 Mar; 12(6):. PubMed ID: 36980256 [TBL] [Abstract][Full Text] [Related]
17. The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications. Basisty N; Kale A; Patel S; Campisi J; Schilling B Expert Rev Proteomics; 2020 Apr; 17(4):297-308. PubMed ID: 32425074 [TBL] [Abstract][Full Text] [Related]
18. The impact of senescence on muscle wasting in chronic kidney disease. Huang Y; Wang B; Hassounah F; Price SR; Klein J; Mohamed TMA; Wang Y; Park J; Cai H; Zhang X; Wang XH J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):126-141. PubMed ID: 36351875 [TBL] [Abstract][Full Text] [Related]
19. Targeting senescence to prevent diabetic kidney disease: Exploring molecular mechanisms and potential therapeutic targets for disease management. Phillips PCA; de Sousa Loreto Aresta Branco M; Cliff CL; Ward JK; Squires PE; Hills CE Diabet Med; 2024 Jul; ():e15408. PubMed ID: 38995865 [TBL] [Abstract][Full Text] [Related]